mannuronic acid has been researched along with Ankylosing Spondylarthritis in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| A Rehm, BH; Aghazadeh, Z; Ahmadi, H; Cuzzocrea, S; Fattahi, MJ; Jafarnezhad-Ansariha, F; Matsuo, H; Mirshafiey, A; Oraei, M; Tofighi-Zavareh, F | 1 |
| Cuzzocrea, S; Esposito, E; Fattahi, MJ; Hashemi, SN; Jafarnezhad-Ansariha, F; Jamshidi, AR; Mahmoudi, M; Mansouri, R; Matsuo, H; Mirshafiey, A; Rehm, BHA; Vojdanian, M; Yekaninejad, MS | 1 |
| Aletaha, S; Barati, A; Fattahi, MJ; Jafarnezhad-Ansariha, F; Mahmoudi, M; Mirshafiey, A; Rezaei, N; Roozbehkia, M | 1 |
| Aghazadeh, Z; Ahmadi, H; Cuzzocrea, S; Fattahi, MJ; Hashemi, SN; Hosseini, M; Jafarnezhad-Ansariha, F; Jamshidi, AR; Mahmoudi, M; Matsuo, H; Mirshafiey, A; Rehm, BHA; Vojdanian, M; Yekaninejad, MS | 1 |
| Ahmadi, H; Cuzzocrea, S; Fattahi, MJ; Jafarnezhad-Ansariha, F; Matsuo, H; Mirshafiey, A; Mortazavi-Jahromi, SS; Rehm, BHA | 1 |
3 trial(s) available for mannuronic acid and Ankylosing Spondylarthritis
| Article | Year |
|---|---|
The effects of β-D-mannuronic acid (M2000), as a novel NSAID, on COX1 and COX2 activities and gene expression in ankylosing spondylitis patients and the murine monocyte/macrophage, J774 cell line.
Topics: Adult; Animals; Anti-Inflammatory Agents, Non-Steroidal; Cell Line; Cyclooxygenase 1; Cyclooxygenase 2; Female; Gene Expression; Hexuronic Acids; Humans; Immunosuppressive Agents; Inflammation; Iran; Macrophages; Male; Mice; Monocytes; Spondylitis, Ankylosing | 2018 |
The potent suppressive effect of β-d-mannuronic acid (M2000) on molecular expression of the TLR/NF-kB Signaling Pathway in ankylosing spondylitis patients.
Topics: Adolescent; Adult; Female; Hexuronic Acids; Humans; Immunity, Innate; Immunosuppressive Agents; Male; Middle Aged; Mitogen-Activated Protein Kinase 14; Myeloid Differentiation Factor 88; NF-kappa B; Signal Transduction; Spondylitis, Ankylosing; Toll-Like Receptor 2; Toll-Like Receptor 4; Treatment Outcome; Young Adult | 2017 |
Evaluation of the efficacy and safety of β-d-mannuronic acid in patients with ankylosing spondylitis: A 12-week randomized, placebo-controlled, phase I/II clinical trial.
Topics: Adult; Anti-Inflammatory Agents; Antirheumatic Agents; Double-Blind Method; Female; Hexuronic Acids; Humans; Iran; Male; Naproxen; Placebo Effect; Severity of Illness Index; Spondylitis, Ankylosing; Treatment Outcome; Young Adult | 2018 |
2 other study(ies) available for mannuronic acid and Ankylosing Spondylarthritis
| Article | Year |
|---|---|
Evaluation of cell adhesion molecules (LFA-1 and L-selectin) in ankylosing spondylitis patients after treatment with β-D-mannuronic acid (M2000).
Topics: Cell Adhesion Molecules; Humans; L-Selectin; Lymphocyte Function-Associated Antigen-1; Spondylitis, Ankylosing | 2023 |
Oral administration effects of β-d-mannuronic acid (M2000) on Th17 and regulatory T cells in patients with ankylosing spondylitis.
Topics: Administration, Oral; Adolescent; Adult; Anti-Inflammatory Agents, Non-Steroidal; Female; Hexuronic Acids; Humans; Immunosuppressive Agents; Male; Middle Aged; Spondylitis, Ankylosing; T-Lymphocytes, Regulatory; Th17 Cells; Young Adult | 2018 |